SCHEMBL28631118

SCHEMBL28631118

C[C@@H](O)[C@H](N)C(=O)N1CSC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)[C@@H](C)O

nearest known ligand 0.49

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CAPN1 P07384 8/20 0.49
▸ CTSB P07858 3/20 0.49
▸ DPP4 P27487 5/20 0.41
▸ DPP7 Q9UHL4 5/20 0.41
▸ PREP P48147 3/20 0.41
▸ XIAP P98170 1/20 0.38
▸ GRB2 P62993 1/20 0.36
▸ ELANE P08246 1/20 0.35
▸ DPP8 Q6V1X1 2/20 0.34
▸ OPRM1 P35372 1/20 0.34
▸ FAP Q12884 2/20 0.33
▸ PITRM1 Q5JRX3 1/20 0.33
▸ DPP9 Q86TI2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28633246 0.92 CAPN1 (0.49) CAPN1CTSBDPP4DPP7PREP
SCHEMBL28634746 0.90 CAPN1 (0.41) CAPN1CTSBDPP4DPP7PREP
SCHEMBL28632981 0.90 CAPN1 (0.41) CAPN1CTSBDPP4DPP7PREP
SCHEMBL28651461 0.90 CAPN1 (0.54) CAPN1CTSBXIAPELANEOPRM1
SCHEMBL28646494 0.90 DPP4 (0.38) CAPN1CTSBDPP4DPP7PREP
SCHEMBL28640695 0.89 CAPN1 (0.41) CAPN1CTSBDPP4DPP7PREP
Rapastinel SCHEMBL25266713 0.88 CAPN1 (0.59) CAPN1CTSBDPP4DPP7PREP
Rapastinel SCHEMBL23859842 0.88 CAPN1 (0.59) CAPN1CTSBDPP4DPP7PREP
Rapastinel SCHEMBL22213513 0.88 CAPN1 (0.59) CAPN1CTSBDPP4DPP7PREP
Rapastinel SCHEMBL23753673 0.88 CAPN1 (0.59) CAPN1CTSBDPP4DPP7PREP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113480596-A Compound for regulating NMDA receptor activity, pharmaceutical composition and application thereof 北京广为医药科技有限公司 2021-10-08 — — CN claimed
CN-110003309-B Compounds that modulate NMDA receptor activity, pharmaceutical compositions and uses thereof 北京广为医药科技有限公司 2021-09-10 — — CN claimed
Send feedback